The global neurodegenerative disease treatment market grew at a CAGR of around 8% during 2015-2020. Neurodegenerative diseases refer to a group of brain disorders that lead to progressive degeneration of the structure and function of neurons in the centra…
Anti-Parkinson Drugs are drugs used to treat Parkinson's disease.
The most commonly used Anti-Parkinson Drugs act on the dopaminergic system of the striatum and basal ganglia, or are central muscarinic antagonists.
Market Analysis and Insights: Global An…
The Neurodegenerative Disease market was valued at approximately USD 39.24 billion in 2020 and is expected to witness a revenue of USD 44.90 billion in 2026, with a CAGR of 2.30% over the forecast period.
The COVID-19 impact on the Neurodegenerative Dise…